This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_MULTIPLE_MYELOMA_PLASMA_CELL_EXALLC for full statistics.
This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_MULTIPLE_MYELOMA_PLASMA_CELL_EXALLC for full statistics.
CD2_MULTIPLE_MYELOMA_PLASMA_CELL
multiple myeloma: A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
1292
Check minimum number of events None
1292
Include endpoints None
1292
Remove individuals based on genotype QC
1249
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
List of similar endpoints to Multiple myeloma and malignant plasma cell neoplasms based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 1249 | 548 | 701 |
Unadjusted prevalence (%) | 0.33 | 0.26 | 0.42 |
Mean age at first event (years) | 66.81 | 65.43 | 67.90 |
Not a core endpoint, no data to show.
Not a core endpoint, no data to show.
Index endpoint: CD2_MULTIPLE_MYELOMA_PLASMA_CELL – Multiple myeloma and malignant plasma cell neoplasms
GWS hits:
before Multiple myeloma and malignant plasma cell neoplasms
after Multiple myeloma and malignant plasma cell neoplasms
Loading survival analyses plot
Loading survival analyses table